2 ML golodirsen 50 MG/ML Injection [Vyondys 53]
- RxCUI
- 2267216
- RxNorm name
- 2 ML golodirsen 50 MG/ML Injection [Vyondys 53]
- Display name
- 2 ML golodirsen 50 MG/ML Injection [Vyondys 53]
- Full name
- 2 ML golodirsen 50 MG/ML Injection [Vyondys 53]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vyondys 53 | GOLODIRSEN | Sarepta Therapeutics, Inc. | 35c227d1-5b24-44b0-b5d3-f0f6b1c46bd5 | 2025-03-13 | Warnings, Adverse reactions | 2267216 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 35c227d1-5b24-44b0-b5d3-f0f6b1c46bd5 | VYONDYS 53 Injection 100 MG in 2 ML [PSN] · 2 ML golodirsen 50 MG/ML Injection [Vyondys 53] [SBD] · 2 ML Vyondys 53 50 MG/ML Injection [SY] · VYONDYS 53 Injection 100 MG per 2 ML [SY] | 4 | 16 | These highlights do not include all the information needed to use VYONDYS 53 safely and effectively. See full prescribing information for VYONDYS 53. VYONDYS 53 (golodirsen) injection, for intravenous use Initial U.S. Approval: 2019 | 20250313 |